Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers

Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers

A study to compare the pharmacokinetic(s) of K-877 and CSG452 when each drug is administered alone and when both are administered together.

Inclusion Criteria:

• Subject provides written informed consent before any study-specific evaluation is performed.
• Subject is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive, at Screening.
• Subject has a BMI of 18 to 30 kg/m2, inclusive, at Screening.
• Subject meets all other inclusion criteria outlined in the clinical study protocol

Exclusion Criteria:

• Subject has clinically relevant abnormalities at Screening or at Check-in assessments.
• Subject is pregnant or breastfeeding or intends to become pregnant within 30 days after the last dose of study drug.
• Subject does not meet any other exclusion criteria outlined in the clinical study protocol.